Bone defects remain difficult to treat because conventional grafting approaches may cause infection, inflammation, donor-site morbidity, or graft rejection. Mesoporous silica nanoparticles (MSNs) have emerged as versatile nanomaterials for drug delivery owing to their large surface area, tunable pore structure, high lo...